0001144204-17-012939.txt : 20170306 0001144204-17-012939.hdr.sgml : 20170306 20170306160515 ACCESSION NUMBER: 0001144204-17-012939 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170306 FILED AS OF DATE: 20170306 DATE AS OF CHANGE: 20170306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRAINSTORM CELL THERAPEUTICS INC. CENTRAL INDEX KEY: 0001137883 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 207273918 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 UNIVERSITY PLAZA DRIVE STREET 2: SUITE 320 CITY: HACKENSACK STATE: NJ ZIP: 07601 BUSINESS PHONE: 201-488-0460 MAIL ADDRESS: STREET 1: 3 UNIVERSITY PLAZA DRIVE STREET 2: SUITE 320 CITY: HACKENSACK STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: BRAINSTORM CELL THERAPEUTICS INC DATE OF NAME CHANGE: 20041122 FORMER COMPANY: FORMER CONFORMED NAME: GOLDEN HAND RESOURCES INC DATE OF NAME CHANGE: 20030827 FORMER COMPANY: FORMER CONFORMED NAME: WIZBANG TECHNOLOGIES INC DATE OF NAME CHANGE: 20010409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kern Ralph Dr. CENTRAL INDEX KEY: 0001699684 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36641 FILM NUMBER: 17667887 MAIL ADDRESS: STREET 1: C/O BRAINSTORM CELL THERAPEUTICS, INC. STREET 2: 3 UNIVERSITY PLAZA DRIVE, SUITE 320 CITY: HACKENSACK STATE: NJ ZIP: 07601 3 1 v461201_3.xml OWNERSHIP DOCUMENT X0206 3 2017-03-06 1 0001137883 BRAINSTORM CELL THERAPEUTICS INC. BCLI 0001699684 Kern Ralph Dr. C/O BRAINSTORM CELL THERAPEUTICS, INC. 3 UNIVERSITY PLAZA DRIVE, SUITE 320 HACKENSACK NJ 07601 0 1 0 0 COO and Chief Medical Officer /s/ Nathaniel Gaede (pursuant to Power of Attorney) 2017-03-06 EX-24 2 v461201_ex24.htm EXHIBIT 24

Exhibit 24

Brainstorm cell therapeutics inc.

LIMITED Power of Attorney

This statement confirms that the undersigned has authorized and designated each of Nathaniel Gaede and Thomas B. Rosedale as attorneys-in-fact to (i) prepare, execute and file on behalf of the undersigned Form ID or any other necessary documents or forms in order to obtain access codes (including, without limitation, CIK and CCC codes) for the undersigned to permit filing on EDGAR, and (ii) prepare, execute and file on behalf of the undersigned all Forms 3, 4 and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Brainstorm Cell Therapeutics Inc. The authority of such attorneys under this Power of Attorney shall continue until the undersigned is no longer required to file Forms 3, 4 and 5 with regard to the undersigned's ownership of or transactions in securities of Brainstorm Cell Therapeutics Inc., unless earlier revoked in writing. The undersigned acknowledges that such attorneys are not assuming any of the undersigned's responsibilities to comply with the requirements of Section 16 of the Securities Exchange Act of 1934, as amended, or any of the undersigned's liabilities for failure to comply with such requirements.

Date: March 2, 2017	/s/ Dr. Ralph Kern
	Name: Dr. Ralph Kern